Treatment of full thickness cartilage lesions with a 3D Printed Nanochon Implant in an Equine model
Charlotte K Barton BVSc, MS, DACVS-LA, MS, MS, Katie A Seabaugh DVM, MS, DACVS-LA, DACVSMR, Ben Gadomski BS, PhD, Kevin Labus PhD, Ben Holmes BS,
Charlotte K Barton BVSc, MS, DACVS-LA, MS, MS, Katie A Seabaugh DVM, MS, DACVS-LA, DACVSMR, Ben Gadomski BS, PhD, Kevin Labus PhD, Ben Holmes BS,
The Maryland Stem Cell Research Commission, the body overseeing The Maryland Stem Cell Research Fund (MSCRF), has awarded Nanochon grant funding to support its manufacturing
Washington, DC, July 14 2025 – Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects
Under the direction of CEO Benjamin Holmes, Nanochon, Inc. is set to revolutionize the treatment of cartilage loss and damage. The company’s Chondrograft™ implant, a
LaunchPort is pleased to announce that Nanochon has joined their City Garage/Baltimore Peninsula location as a LaunchPort Resident. “Over the last three years, Nanochon has
LOS ANGELES-MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced its 2024 Accelerator Cohort. After a competitive selection process with a five percent
WASHINGTON–Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The
Founded in 2016, Nanochon aims to facilitate cartilage replacement and repair for patients suffering from knee injuries. It relies on 3D printing technology, specifically extrusion,
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today